Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimemorfan phosphate syrup in pediatric cough due to respiratory infection
CTR20160407Phase 3Suspended
- Sponsor
- Shandong Bainuo Pharmaceutical
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dimemorfan in cough, upper respiratory infection (URI), acute bronchitis, pneumonia, sponsored by Shandong Bainuo Pharmaceutical. Started Aug 2016; status: suspended.
02
Drugs
dimemorfan
03
Conditions
coughupper respiratory infection (URI)acute bronchitispneumonia
Beyond the preview
Go deeper on CTR20160407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160407.